CLRB

Cellectar Biosciences (CLRB)

Cellectar Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CLRB

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/14	19:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/05/14	19:40	GlobeNewswire Inc.	Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/05/14	19:32	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/05/08	19:40	GlobeNewswire Inc.	Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/05/07	19:40	GlobeNewswire Inc.	Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/03/27	19:40	GlobeNewswire Inc.	Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/03/20	19:40	GlobeNewswire Inc.	Cellectar Biosciences to Announce 2023 Year End Earnings Results and Host a Conference Call on Wednesday, March 27, 2024	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/03/14	21:52	GlobeNewswire Inc.	Cellectar Biosciences to Present at the 36th Annual Roth Conference	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/03/04	20:40	GlobeNewswire Inc.	Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck Cancer	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/02/15	10:31	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/02/15	06:29	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/02/07	20:40	GlobeNewswire Inc.	Cellectar Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/02/02	20:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/01/31	22:00	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/01/30	20:40	GlobeNewswire Inc.	Cellectar Biosciences Announces Enrollment of the First Patient in Pediatric High-Grade Gliomas Phase 1b Clinical Study	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/01/26	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/01/25	20:40	GlobeNewswire Inc.	Cellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 Million	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/01/22	20:40	GlobeNewswire Inc.	Cellectar Biosciences Reports Complete Central Nervous System (CNS) Clearance in Relapsed/Refractory Waldenstrom’s Macroglobulinemia Patient	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/01/16	20:40	GlobeNewswire Inc.	Cellectar Biosciences Broadens Pipeline with Targeted Alpha Therapy (TAT) for Solid Tumors and Releases Promising Preclinical Data	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/01/12	20:44	GlobeNewswire Inc.	Cellectar Biosciences to Host Conference Call with Texas Oncology Hematologist M. Yair Levy, M.D. on January 19, 2024 to Discuss Iopofosine I 131 Pivotal Topline Results	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/01/11	20:40	GlobeNewswire Inc.	Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/01/09	20:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/01/08	20:30	GlobeNewswire Inc.	Cellectar Biosciences Announces Positive Topline Data Achieving Primary Endpoint in Pivotal Clinical Study of Iopofosine I 131 in Waldenstrom’s Macroglobulinemia	NASDAQ:CLRB	Cellectar Biosciences Inc
2024/01/03	22:30	GlobeNewswire Inc.	Cellectar Biosciences to Announce Top-line Data from WM Pivotal Trial on January 8, 2024	NASDAQ:CLRB	Cellectar Biosciences Inc
2023/12/19	22:30	GlobeNewswire Inc.	Cellectar Biosciences Expands Iopofosine I 131 Collaboration with Wisconsin Alumni Research Foundation	NASDAQ:CLRB	Cellectar Biosciences Inc
2023/12/13	10:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLRB	Cellectar Biosciences Inc
2023/12/13	10:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLRB	Cellectar Biosciences Inc
2023/12/13	10:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLRB	Cellectar Biosciences Inc
2023/12/13	10:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLRB	Cellectar Biosciences Inc
2023/12/12	22:30	GlobeNewswire Inc.	Cellectar Biosciences Strengthens Intellectual Property Protection for its PDC Platform	NASDAQ:CLRB	Cellectar Biosciences Inc